Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bioceres Crop Solutions | BIOX | Nov 22, 2024 | 6.13 | -4.81 |
BioCryst Pharmaceuticals | BCRX | Nov 22, 2024 | 7.60 | +1.47 |
Biodesix | BDSX | Nov 22, 2024 | 1.28 | +6.67 |
Biodexa Pharma ADR | BDRX | Nov 22, 2024 | 4.57 | +3.86 |
Biofrontera | BFRI | Nov 22, 2024 | 0.87 | +14.62 |
Biogen | BIIB | Nov 22, 2024 | 157.90 | -0.07 |
BioHarvest Sciences | BHST | Nov 22, 2024 | 6.22 | 0.00 |
Biohaven | BHVN | Nov 22, 2024 | 45.59 | +0.89 |
BioLife Solutions | BLFS | Nov 22, 2024 | 26.01 | +2.44 |
BioLineRX ADR | BLRX | Nov 22, 2024 | 0.28 | -13.97 |
BioMarin Pharmaceutical | BMRN | Nov 22, 2024 | 64.26 | +1.28 |
Biomea Fusion | BMEA | Nov 22, 2024 | 6.44 | +0.94 |
Biomerica | BMRA | Nov 22, 2024 | 0.31 | -2.94 |
BiomX | PHGE | Nov 22, 2024 | 0.54 | +10.76 |
Bionano Genomics | BNGO | Nov 22, 2024 | 0.22 | +2.24 |
BioNexus Gene Lab | BGLC | Nov 22, 2024 | 0.29 | -0.24 |
Bionomics ADR | BNOX | Nov 22, 2024 | 0.29 | +6.00 |
BioNTech ADR | BNTX | Nov 22, 2024 | 113.13 | +4.53 |
Biora Therapeutics | BIOR | Nov 22, 2024 | 1.67 | +2.45 |
BioRestorative Therapies | BRTX | Nov 22, 2024 | 1.48 | +2.42 |
BioShares Biotechnology Clinical Trials Fund | BBC | Nov 22, 2024 | 26.85 | +2.77 |
BioShares Biotechnology Products Fund | BBP | Nov 22, 2024 | 63.86 | +2.91 |
biote | BTMD | Nov 22, 2024 | 5.98 | -2.61 |
Bioventus A | BVS | Nov 22, 2024 | 11.71 | +1.74 |
BioVie | BIVI | Nov 22, 2024 | 3.05 | -1.93 |
BioXcel Therapeutics | BTAI | Nov 22, 2024 | 0.51 | -10.80 |
BIP Bermuda Holdings | BIPI | Nov 22, 2024 | 18.47 | +0.38 |
Birkenstock Holding | BIRK | Nov 22, 2024 | 47.60 | +0.40 |
Birks Group | BGI | Nov 22, 2024 | 1.58 | -1.86 |
Bit Digital | BTBT | Nov 22, 2024 | 4.44 | +11.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.